SCHEMBL7741786

SCHEMBL7741786

CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(C(N)=O)c2)C(=O)O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 7/20 0.56
MLNR O43193 1/20 0.56
NR1I2 O75469 1/20 0.56
ABCB11 O95342 1/20 0.56
PGR P06401 1/20 0.56
CTSD P07339 1/20 0.56
CHRM2 P08172 1/20 0.56
ADRA2A P08913 1/20 0.56
PGA5 P0DJD9 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
CTSE P14091 1/20 0.56
GABRA1 P14867 1/20 0.56
ADRA2C P18825 1/20 0.56
DRD1 P21728 1/20 0.56
HTR2A P28223 1/20 0.56
AGTR1 P30556 1/20 0.56
CCKAR P32238 1/20 0.56
ADRA1A P35348 1/20 0.56
PTGS2 P35354 1/20 0.56
PPARG P37231 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957401 0.88 MLNR (0.58) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL6958382 0.88 MLNR (0.58) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL1324786 0.88 MLNR (0.58) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL6954624 0.88 MLNR (0.58) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL1324788 0.88 MLNR (0.58) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL6174510 0.87 OPRD1 (0.58) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL29071451 0.87 MLNR (0.54) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL29071453 0.87 MLNR (0.54) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL29071454 0.87 MLNR (0.54) OPRD1MLNRNR1I2ABCB11PGR
SCHEMBL6946843 0.85 MLNR (0.63) OPRD1MLNRNR1I2ABCB11PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423718-B1 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-07-23 US claimed